fulvestrant

EP standards - An estrogen receptor antagonist, Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women. It is administered intramuscularly. Reference standards of Fulvestrant API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Fulvestrant (Y0001399)
    [catalogue_number] => PA EPY0001399
    [category_ids] => ,150,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => fulvestrant-y0001399-paepy0001399
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA EPY0001399
PA EPY0001399

Fulvestrant (Y0001399)


  • Catalogue No.:PA EPY0001399

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

stdClass Object
(
    [pname] => Fulvestrant for system suitability (Y0001413)
    [catalogue_number] => PA EPY0001413
    [category_ids] => ,150,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => fulvestrant-for-system-suitability-y0001413-paepy0001413
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA EPY0001413
PA EPY0001413

Fulvestrant for system suitability (Y0001413)


  • Catalogue No.:PA EPY0001413

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

pharmaffiliates